Clinical trial
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell…
NCT00003898 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003898 |
|---|---|
| Title | Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation |
| Official title | The Use of Supplemental Oral Glutamine (GLN) to Decrease Morbidity in Patients Undergoing Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Study |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Oral Complications, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement |
| Interventions | glutamine |
| Enrollment | 120 |
| Start date | Jan 1, 1999 |
| Primary completion | Jun 1, 2003 |
| Completion | Jan 1, 2004 |
| First posted | Jun 17, 2004 |
| Last update posted | Mar 1, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: